360 ONE Capital Research has gone with a classic long-term investing playbook for October: own the lenders, utilities, consumer staples and industrials that can compound steadily even if the market gets choppy. That matters because the brokerage’s eight stock picks are not a trading list so much as a bet that India’s next phase of earnings growth will come from durable businesses with pricing power, balance-sheet strength and exposure to structural demand.
360 ONE Capital October stock picks in India

The most important takeaway is that the firm is leaning into sectors that can benefit from a resilient domestic economy rather than chasing momentum. Coal India and NTPC tap India’s still-heavy dependence on thermal power, even as renewable capacity rises. ICICI Bank and SBI Life reflect a preference for financial companies with distribution reach and steady growth. ITC underscores how pricing power can still matter more than volume in a tax-heavy environment. Aurobindo Pharma, Jindal SAW and the rest round out the list with specific operational catalysts, but the broader message is clear: investors should think about earnings durability, not just short-term market noise.
Coal India stands out because the case is built on demand, not hope. The brokerage expects coal offtake to improve as power plants rebuild inventories and thermal generation remains strong, while higher e-auction premiums could lift realizations and margins. NTPC gets a similar vote of confidence, with robust power demand, improving coal-based plant load factors and the longer-term renewable and nuclear build-out supporting growth. For investors, that combination is important: India is still likely to need conventional power to keep the grid stable, even as the clean-energy transition gathers pace.
The financials on the list point to a different but equally powerful theme. ICICI Bank is backed by strong credit growth, a healthy liability franchise and asset quality that is expected to stay under control. SBI Life, meanwhile, is expected to see margins normalize as product mix improves and GST-related input tax credit effects fade, while retail annualized premium equivalent growth stays healthy. In plain English, these are businesses that can keep compounding if loan demand holds up and insurers continue to deepen customer relationships.
ITC’s inclusion is a reminder that dividend-friendly consumer franchises still matter in a volatile market. 360 ONE Capital expects pricing power to outweigh cigarette volume declines after recent tax hikes, with staggered price increases in established brands helping offset weaker volumes. That is the kind of steady cash-flow story long-term investors often want in a diversified portfolio, especially when broader equity sentiment can swing quickly.
Aurobindo Pharma and Jindal SAW add a more cyclical layer to the list. Aurobindo’s growth is tied to new product ramps and a longer runway in the U.S., while Jindal SAW’s outlook depends on execution improvements, better capacity use and new orders. Those are the sort of names that can do well if operating leverage kicks in, but they also remind investors that even in a quality-biased portfolio, the upside often comes from companies with specific catalysts rather than broad macro optimism alone.
The broader market backdrop helps explain why a stock-picking list like this matters now. Indian large caps have been correcting and technical readings in several of the market leaders look stretched to the downside, with some names trading below their 50-day moving averages and momentum indicators weak. That does not change the long-term thesis, but it does reinforce the case for buying businesses with visible earnings power instead of trying to time every swing. For long-term investors, the lesson is simple: the best October list is the one that can still look sensible in 2028.
If you are building a portfolio for the next three to ten years, 360 ONE Capital’s picks are worth studying as a map of where India’s compounding engines may come from — power, banks, insurance, staples, pharma and industrials. The right approach is not to own all eight names blindly, but to use them as a watchlist and compare each against your existing holdings, valuation discipline and diversification goals.
| Entity | Gains | Losses |
|---|---|---|
| Coal India, NTPC | ▲Steady power demand; stronger realizations | ▼Coal importers; power buyers facing higher fuel costs |
| ICICI Bank, SBI Life | ▲Credit growth; retail financial deepening | ▼Slow-growth lenders; weaker insurers |
| ITC | ▲Pricing power and cash flow | ▼Volume-sensitive rivals |
| Aurobindo Pharma, Jindal SAW | ▲Product launches; execution upside | ▼Companies lacking clear catalysts |

